Tag: Carotid disease
“Nothing but zeros”: Post-CREST-2, are innovative carotid stent designs set to...
"We've had changes in our EVAR devices, we've had changes in our CLTI , lower extremity, PAD intervention devices, so it only...
CGUARDIANS II shows positive 30-day outcomes for carotid stent use in...
InspireMD, developer of the CGuard Prime carotid stent system, has announced positive 30-day outcomes from the CGUARDIANS II clinical trial of the CGuard Prime...
First patient enrolled in InspireMD’s CGUARDIANS III pivotal study of neuro...
InspireMD today announced that the first patient has been enrolled in the CGUARDIANS III pivotal study of its SwitchGuard neuro protection system (NPS), for...
“Excellent” one-year outcomes from ROADSTER 3 show TCAR is “safe and...
One-year outcomes in the ROADSTER 3 post-approval study to evaluate the safety and effectiveness of transcarotid artery revascularisation (TCAR) using the Enroute stent and...
ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on...
Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularisation (TCAR) is a safe and effective approach in patients who are...
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularisation (TCAR).
"The integration of the TCAR platform into our portfolio...
Smoking cessation remains a “ripe target” for improved medication adherence in...
New data presented at the 2024 Vascular Annual Meeting (VAM; 19–22 June, Chicago, USA) have revealed poor overall rates of medical therapy adherence in...
Single-centre analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
Evidence, timing and medical therapy: Key carotid questions addressed at VSASM...
Extolling the benefits of evidence-based practice, timely surgical intervention and intensive medical therapy, Dominic PJ Howard (Oxford, UK) spoke at the Vascular Society of...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
Sex found to be “important variable” in study and treatment of...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Age is just a number: Individual patient data meta-analysis probes safety...
A newly published meta-analysis of individual patient data has found that older patients with symptomatic carotid disease are likely to benefit as much from...
Endarterectomy and TCAR “continue to show superior outcomes” to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Research indicates low stroke risk and benefit of medication alone in...
The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be...
